The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients

Yonsei Medical Journal

Volumn 48, Issue 2, 2007, Pages 274-280

  Ozdemir, Ali ^a,b   Yalinbas, Berrin ^a   Selamet, Umut ^a   Eres, Meltem ^a   Turkmen, Funda ^a   Kumbasar, Fatma ^c   Murat, Berna ^a   Keskin, A Tayfun ^a   Barut, Yildiz ^a  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Biochemical Laboratories ^*  (Turkey)

^c Biochemical Laboratories   (Turkey)

Author keywords

Haemodialysis; HCV; Insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; FERRITIN; GLUCOSE; INSULIN; MAGNESIUM; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCORING SYSTEM;

ADULT; C-PEPTIDE; FEMALE; HEPATITIS C; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34248224567     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.2.274     Document Type: Article

References (36)

1. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Peitte JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204-12.
2. Ignatova TM, Aprosina ZG, Serov VV, Mukhin NA, Krel' PE, Semenkova EN, et al. Extrahepatic manifestations of chronic hepatitis C. Ter Arkh 1998;70:9-16.
3. Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J Viral Hepat 1998;5:179-85.
4. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133: 592-9.
5. Caronia S, Taylor K, Pagliara L, Carr C, Palazzo U, Petrik J, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30:1059-63.
6. Alexander GJ. An association between hepatitis C virus infection and type 2 diabetes mellitus: What is the connection? Ann Intern Med 2000;133:650-2.
7. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29:328-33.
8. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in non cirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000;75:355-9.
9. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9.
10. Bigam DL, Pennington JJ, Carpentier A, Wanless IR, Hemming AW, Croxford R, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000;32:87-90.
11. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996;19:998-1000.
12. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, et al. Risk factors of diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001;35:279-83.
13. el-Zayadi AR, Selim OE, Hamdy H, Dabbous H, Ahdy A, Moniem SA. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998;19:141-4.
14. Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996;20: 544-8.
15. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981;67:563-8.
16. Bagdade JD. Disorders of glucose metabolism in uremia. Adv Nephrol Necker Hosp 1979;8:87-100.
17. Rasic-Milutinovic, Perunicic-Pekovic G. Clinical importance and pathogenetic mechanisms of insulin resistance in chronic renal insufficiency (part I): Insulin resistance in patients with chronic renal insufficiency. Med Pregl 2000;53:45-50.
18. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001;89:348-9.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
20. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
21. Shinohara K, Shoji T, Emoto M, Tahara, II, Koyama II, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal failure. J Am Soc Nephrol 2002;13: 1894-900.
22. Yildiz A, Tutuncu Y, Yazici H, Akkaya V, Kayacan SM, Sever MS, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation 2002;74:1109-13.
23. Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2000;15:65-70.
24. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index a non-diabetic population. Med Clin(Barc) 2001;117:530-3.
25. Regeur L, Faber OK, Binder C. Plasma C-peptide in uremic patients. Scand J Clin Lab Invest 1978;38:771-5.
26. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, et al. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kidney Dis 2001;38:1009-15.
27. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
28. Saab S, Martin P, Brezina M, Gitnick G, Yee HF Jr. Serum alanine aminotransferase in hepatitis c screening of patients on haemodialysis. Am J Kidney Dis 2001;37:308-15.
29. Yasudu K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypoaminotransferasemia in patients undergoing long-term haemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109: 1295-300.
30. Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 2002;51:544-8.
31. Caro JF. Clinical review 26: insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991;73: 691-5.
32. Hernandez C, Genesca J, Ignasi Esteban J, Garcia L, Simo R. Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study. Med Clin(Barc) 2000;115:21-2.
33. Hague S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996;27:1277-81.
34. Mak RH. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 1998;53: 1353-7.
35. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47:200-6.
36. Fox C, Ramsoomair D, Carter C. Magnesium: its proven and potential clinical significance. South Med J 2001;94:1195-201.